BHCM
Brevan Howard Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $622K | Buy |
361,803
+254,188
| +236% | +$437K | ﹤0.01% | 1172 |
|
|
2025
Q1 | $358K | Buy |
107,615
+95,653
| +800% | +$319K | ﹤0.01% | 766 |
|
|
2024
Q4 | $88.5K | Sell |
11,962
-22,159
| -65% | -$164K | ﹤0.01% | 945 |
|
|
2024
Q3 | $320K | Buy |
34,121
+10,350
| +44% | +$97.2K | ﹤0.01% | 771 |
|
|
2024
Q2 | $191K | Sell |
23,771
-209,559
| -90% | -$1.68M | ﹤0.01% | 852 |
|
|
2024
Q1 | $3.46M | Sell |
233,330
-459,445
| -66% | -$6.81M | 0.03% | 59 |
|
|
2023
Q4 | $5.63M | Sell |
692,775
-869,911
| -56% | -$7.07M | 0.07% | 17 |
|
|
2023
Q3 | $7.11M | Buy |
1,562,686
+81,251
| +5% | +$370K | 0.09% | 9 |
|
|
2023
Q2 | $10.4M | Buy |
1,481,435
+947,265
| +177% | +$6.67M | 0.22% | 12 |
|
|
2023
Q1 | $3.26M | Buy |
534,170
+254,338
| +91% | +$1.55M | 0.09% | 36 |
|
|
2022
Q4 | $1.79M | Hold |
279,832
| – | – | 0.06% | 32 |
|
|
2022
Q3 | $2.68M | Buy |
279,832
+75,774
| +37% | +$726K | 0.1% | 19 |
|
|
2022
Q2 | $2.25M | Buy |
+204,058
| New | +$2.25M | 0.09% | 10 |
|